APA (7th ed.) Citation

A, B., A, B., K, C., K, S., G, M., D, H., . . . U, P. (2026). Impact of allogeneic stem cell transplantation in patients with higher risk myelodysplastic syndromes. Blood cancer journal, 16(1), . https://doi.org/10.1038/s41408-026-01479-x

Chicago Style (17th ed.) Citation

A, Bazinet, et al. "Impact of Allogeneic Stem Cell Transplantation in Patients with Higher Risk Myelodysplastic Syndromes." Blood Cancer Journal 16, no. 1 (2026). https://doi.org/10.1038/s41408-026-01479-x.

MLA (9th ed.) Citation

A, Bazinet, et al. "Impact of Allogeneic Stem Cell Transplantation in Patients with Higher Risk Myelodysplastic Syndromes." Blood Cancer Journal, vol. 16, no. 1, 2026, https://doi.org/10.1038/s41408-026-01479-x.